A possible explanation for these conflicting findings could be that patients with behavioral variant FTD usually present with changes in personality and behavior, while patients with CHMP2B-FTD initially present with executive dysfunction while behavioral symptoms appear at a later stage of the disease (Stokholm et al., 2013). The gene discussed is CHMP2B; the disease is frontotemporal dementia.